Literature DB >> 3877663

Vitamin D status in Crohn's disease: association with nutrition and disease activity.

A D Harries, R Brown, R V Heatley, L A Williams, S Woodhead, J Rhodes.   

Abstract

Forty patients with Crohn's disease were divided into undernourished (18) and well nourished (22) groups depending on whether their midarm circumference was below or above 90% of the ideal standard. Plasma 25-(OH)D3 and the dihydroxylated metabolites, 24,25-(OH)2D3 and 1,25-(OH)2D3 were measured in the summer. Results were related to clinical and biochemical parameters and also compared with results from patients with ulcerative colitis and healthy subjects who served as controls. Plasma 25-(OH)D3 was reduced in the undernourished Crohn's group compared with the well nourished Crohn's group, who did not differ from the controls. Over 50% of the undernourished Crohn's group had evidence of secondary hyperparathyroidism and raised alkaline phosphatase concentrations, although concentrations of 1,25-(OH)2D3 were normal. The low 25-(OH)D3 concentrations related to disease activity. It is suggested that undernourished Crohn's patients who have high levels of disease activity are at risk of vitamin D deficiency, and attempts should be made to improve their vitamin D nutrition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877663      PMCID: PMC1432925          DOI: 10.1136/gut.26.11.1197

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  25-hydroxycholecalciferol serum levels in patients with Crohn's disease.

Authors:  A Sonnenberg; H Ehms; G E Sonnenberg; G Strohmeyer
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1977-08

2.  Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients.

Authors:  D A Goldstein; Y Oda; K Kurokawa; S G Massry
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

3.  High phytate content of rural Iranian bread: a possible cause of human zinc deficiency.

Authors:  J G Reinhold
Journal:  Am J Clin Nutr       Date:  1971-10       Impact factor: 7.045

4.  The incidence and significance of liver dysfuntion in Crohn's disease.

Authors:  N H Dyer; A M Dawson
Journal:  Digestion       Date:  1972       Impact factor: 3.216

5.  Studies of vitamin D deficiency in man.

Authors:  M A Preece; C A Ribot; J Pietrek; H T Korn; D M Davies; J A Ford; M G Dunnigan; J L O'Riordan
Journal:  Q J Med       Date:  1975-10

6.  Experimental siderosis in the rabbit: correlation between electroretinography and histopathology.

Authors:  S S Declercq; P C Meredith; A R Rosenthal
Journal:  Arch Ophthalmol       Date:  1977-06

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Changes in plasma half-life and clearance of 3H-25-hydroxyvitamin D3 in patients with intestinal malabsorption.

Authors:  A J Batchelor; G Watson; J E Compston
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

9.  Osteomalacia after small-intestinal resection.

Authors:  J E Compston; A B Ayers; L W Horton; J R Tighe; B Creamer
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

10.  Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection.

Authors:  J E Compston; B Creamer
Journal:  Gut       Date:  1977-03       Impact factor: 23.059

View more
  42 in total

1.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 2.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

3.  Reduced bone density in patients with inflammatory bowel disease.

Authors:  I Bjarnason; A Macpherson; C Mackintosh; M Buxton-Thomas; I Forgacs; C Moniz
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

Review 4.  Linking vitamin d deficiency to inflammatory bowel disease.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

5.  Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation.

Authors:  Rachael M Biancuzzo; Nigel Clarke; Richard E Reitz; Thomas G Travison; Michael F Holick
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

6.  Vitamin D status in children and young adults with inflammatory bowel disease.

Authors:  Helen M Pappa; Catherine M Gordon; Tracee M Saslowsky; Anna Zholudev; Brian Horr; Mei-Chiung Shih; Richard J Grand
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

Review 7.  Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Authors:  Manisha Harpavat; David J Keljo
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 8.  Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review.

Authors:  Krista M Reich; Richard N Fedorak; Karen Madsen; Karen I Kroeker
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.

Authors:  Jie Du; Yunzi Chen; Yongyan Shi; Tianjing Liu; Yong Cao; Yue Tang; Xin Ge; Hongguang Nie; Changqing Zheng; Yan Chun Li
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

10.  Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease.

Authors:  P I Croucher; S Vedi; R J Motley; N J Garrahan; M R Stanton; J E Compston
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.